Indicaid® COVID-19 Rapid Antigen Test

Type: RT-Antigen

CLIA: (CLIA) waived – Requires Companies CLIA Number

Test Count: 25

The INDICAID® COVID-19 Rapid Antigen Test is a lateral flow immunoassay designed for the objective identification of SARS-CoV-2 antigens. Antigen tests are designed to detect proteins from the virus that causes COVID-19 through swab specimens taken from a patient’s nose.

INDICAID® Point-of-Care (PoC) professional is a reliable indicator for COVID-19 in the laboratory, office, attended events & more.

Batch-collection & bulk-testing of individual samples

With the intuitive vial design, INDICAID® PoC (Point-of-Care) Professional Rapid Antigen Tests allow for the aggregate collection of multiple specimens followed by batch-testing of individual samples up to two (2) hours after collection, in the laboratory setting.

Product Specifications:

Tests/Box 25
Sample type Anterior Nasal swab
Time to results 20 minutes
Sensitivity
97%
Specificity
84%
Accuracy 95.6%
Shelf life 12 months
Storage 36° – 86°F (2° – 30°C)
CLIA complexity Waived*
Certification FDA EUA